EP 1842068 A1 20071010 - USE OF MULTIPARAMETRIC FLOW CYTOMETRY FOR THE DIAGNOSIS, PROGNOSIS, AND VALIDATION OF IMMUNOTHERAPIES IN AUTOIMMUNE, HEMATOLOGIC, AND LYMPHOPROLIFERATIVE DISEASES
Title (en)
USE OF MULTIPARAMETRIC FLOW CYTOMETRY FOR THE DIAGNOSIS, PROGNOSIS, AND VALIDATION OF IMMUNOTHERAPIES IN AUTOIMMUNE, HEMATOLOGIC, AND LYMPHOPROLIFERATIVE DISEASES
Title (de)
VERWENDUNG VON MEHRFACHPARAMETER-DURCHFLUSSZYTOMETRIE ZUR DIAGNOSE, PROGNOSE UND VALIDIERUNG VON IMMUNTHERAPIEN BEI AUTOIMMUN-, HÄMATOLOGISCHEN UND LYMPHOPROLIFERATIVEN KRANKHEITEN
Title (fr)
UTILISATION DE CYTOMETRIE DE FLUX MULTIPARAMETRIQUE POUR DIAGNOSTIC, PRONOSTIQUE ET VALIDATION D'IMMUNOTHERAPIES POUR MALADES AUTOIMMUNES, HEMATOLOGIQUES ET LYMPHOPROLIFERATIVES
Publication
Application
Priority
IT 2004000352 W 20040621
Abstract (en)
[origin: WO2005124350A1] This invention concerns a method which allows to perform flow cytometric analysis using determined antibody combinations. These antibodies are conjugated with different fluorochromes, and the antibody combinations include several panels which allow to perform an analysis of the immunological status of the individual (in case of screening for autoimmune disorders or chronic infections) or a detailed study of neoplastic cell populations (when screening for haematological diseases). Antibodies are aliquoted in small tubes at predetermined concentrations, and then lyophilised.
IPC 8 full level
G01N 33/564 (2006.01); G01N 15/14 (2006.01); G01N 33/569 (2006.01); G01N 33/574 (2006.01); G01N 1/42 (2006.01)
CPC (source: EP)
G01N 15/1459 (2013.01); G01N 33/564 (2013.01); G01N 33/56966 (2013.01); G01N 1/42 (2013.01); G01N 2015/1477 (2013.01); G01N 2333/705 (2013.01)
Citation (search report)
See references of WO 2005124350A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
DOCDB simple family (application)
IT 2004000352 W 20040621; EP 04745177 A 20040621